8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with hydralazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cross, AJ; Davies, EM; DeSouza, RJ; Green, AR | 1 |
| Fornal, CA; Jacobs, BL; Litto, WJ; Morilak, DA | 1 |
| Fornal, CA; Jacobs, BL; Martin-Cora, FJ | 1 |
3 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and hydralazine
| Article | Year |
|---|---|
The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain Chemistry; Calcium Channel Blockers; Felodipine; Hydralazine; Hydroxyindoleacetic Acid; Male; Methoxydimethyltryptamines; Mice; Mice, Inbred C57BL; Rats; Receptors, Serotonin; Serotonin; Species Specificity; Tetrahydronaphthalenes; Tranylcypromine; Tryptophan | 1990 |
Single-unit responses of serotonergic neurons to vasoactive drug administration in behaving cats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Blood Pressure; Cats; Female; Heart Rate; Hydralazine; Injections, Intravenous; Male; Methoxydimethyltryptamines; Neurons; Nitroprusside; Phenylephrine; Raphe Nuclei; Serotonin; Serotonin Antagonists; Sleep Stages; Tetrahydronaphthalenes | 1990 |
Single-unit responses of serotonergic medullary raphe neurons to cardiovascular challenges in freely moving cats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Behavior, Animal; Cardiovascular Physiological Phenomena; Cats; Electrocardiography; Electromyography; Electrooculography; Heart Rate; Hemorrhage; Hydralazine; Male; Neurons; Nitric Oxide Donors; Nitroprusside; Phenylephrine; Piperazines; Pyridines; Raphe Nuclei; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sleep Stages; Vasodilator Agents; Wakefulness | 2005 |